Transgene Biotek Stock Screener | Share Price & Fundamental Analysis
TRABI
Healthcare Service Provider
Screen Transgene Biotek share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹2.86
▼
-0.09 (-3.05%)
Market Cap
₹23.24 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.30
EPS (TTM)
₹-0.09
Dividend Yield
-
Debt to Equity
1.38
52W High
₹5.08
52W Low
₹2.72
Operating Margin
-675.00%
Profit Margin
-
EBITDA
₹-1.00
Net Income
₹-1.00
Total Assets
₹144.00
Total Equity
₹10.00
Transgene Biotek Share Price History - Stock Screener Chart
Screen TRABI historical share price movements with interactive charts. Analyze price trends and patterns.
Transgene Biotek Company Profile - Fundamental Screener
Screen Transgene Biotek company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRABI shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE773D01018
Transgene Biotek Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TRABI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 144 | 142 | 142 | 147 | 157 | 167 | 177 | 187 | 198 | 313 |
| Current Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 |
| Fixed Assets | 8 | 6 | 6 | 11 | 21 | 31 | 41 | 51 | 61 | 141 |
| Liabilities | ||||||||||
| Total Liabilities | 144 | 142 | 142 | 147 | 157 | 167 | 177 | 187 | 198 | 313 |
| Current Liabilities | 121 | 121 | 121 | 121 | 121 | 120 | 120 | 120 | 128 | 127 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 11 | 11 | 17 | 22 | 33 | 44 | 52 | 59 | 174 |
| Share Capital | 76 | 76 | 76 | 76 | 76 | 76 | 76 | 76 | 76 | 76 |
| Reserves & Surplus | -66 | -65 | -64 | -58 | -54 | -43 | -32 | -23 | -17 | 99 |
Screen TRABI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| EBITDA | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Operating Profit % | -675.00% | -280.00% | -160.00% | -520.00% | -820.00% | -133.00% | -113.00% | 0.00% | -120.00% | -240.00% | -200.00% | -56.00% | -233.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | -3 | -1 | -2 | -1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 | -3 | -1 | -2 | -1 |
| EPS | -0.09 | -0.06 | -0.05 | -0.04 | 0.03 | -0.01 | -0.01 | -0.19 | -0.02 | -0.02 | -0.02 | -0.34 | -0.18 | -0.23 | -0.18 |
Transgene Biotek Cash Flow Screener - Liquidity Fundamentals
Screen TRABI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 0 | 0 | 0 | 0 | -2 | -1 | 0 | 7 |
| Investing Activities | -2 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 0 | -7 |
| Financing Activities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen TRABI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 71.88% | 71.89% | 71.85% | 71.45% | 71.75% | 71.74% | 71.87% | 71.22% |
| Other Holding | 4.48% | 4.48% | 4.51% | 4.92% | 4.61% | 4.62% | 4.50% | 5.14% |
| Shareholder Count | 13,583 | 13,475 | 13,461 | 12,426 | 12,766 | 12,963 | 13,307 | 11,371 |
Transgene Biotek Dividend Screener - Share Yield Analysis
Screen TRABI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Transgene Biotek Index Membership - Market Screener Classification
Screen TRABI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Transgene Biotek Market Events Screener - Corporate Actions
Screen TRABI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-30 | 2026-12-30 | Annual General Meeting | NA | -28.21% |
| 2025-12-07 | 2025-12-07 | Extraordinary General Meeting | NA | 0.00% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 4.28% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 2.14% |
| 2025-05-07 | 2025-05-07 | Quarterly Result Announcement | NA | -10.03% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 4.20% |
| 2024-12-05 | 2024-12-05 | Annual General Meeting | NA | 0.74% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -3.82% |
| 2023-12-30 | 2023-12-30 | Annual General Meeting | NA | 58.94% |
Transgene Biotek Competitors Screener - Peer Comparison
Screen TRABI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,429 | 44.37 | 2,555 | 11.28% | 492 | 48.87 |
| Vijaya Diagnostic Centre | 10,766 | 70.02 | 700 | 23.06% | 144 | 61.17 |
| Metropolis Healthcare | 9,630 | 61.85 | 1,346 | 10.64% | 146 | 37.00 |
| Thyrocare Technologies | 7,200 | 56.38 | 702 | 20.80% | 91 | 50.51 |
| Nephrocare Health Services | 4,662 | 69.33 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,292 | 27.18 | 743 | 16.70% | 78 | 33.52 |
| Suraksha Diagnostic | 1,389 | 44.34 | 256 | 15.11% | 31 | 30.88 |
| One Global Service Provider | 1,243 | 26.85 | 148 | 134.60% | 19 | 60.04 |
| 3B BlackBio DX | 1,232 | 24.82 | 112 | 28.72% | 48 | 59.23 |
| Sastasundar Ventures | 954 | -105.44 | 1,171 | -18.47% | -134 | 43.45 |
Transgene Biotek Company Announcements - News Screener
Screen TRABI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2026-01-06 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2026-01-06 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2026-01-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-27 | Closure of Trading Window | View |
| 2025-12-05 | Intimation Of Book Closure And Cut -Off Date For The 35Th Annual General Meeting Of Transgene Biotek Limited With Reference To The Subject Cited This Is To Inform That The Register Of Members And The Share Transfer Books Of The Company Will Remain | View |
| 2025-12-05 | Reg. 34 (1) Annual Report. | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Un-Audited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025. (Copy Enclosed) | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On November 14 2025. | View |
| 2025-10-31 | Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On Friday 14Th November 2025 | View |
| 2025-10-17 | Declaration Under Clause 36 Of Listing Agreement With BSE - Intimation About The Filing At NCLT (Hyderabad) Bench By M/S BABAJI NETHRALAYYA PRIVATE LTD | View |
| 2025-10-12 | Compliance-57 (4) : Prior intimation to the beginning of the quarter | View |
| 2025-10-12 | Compliance-57 (5) : intimation after the end of quarter | View |
| 2025-10-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-11 | Compliance Certificate | View |
| 2025-10-11 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | View |
| 2025-10-11 | Statement Of Deviation & Variation | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-08 | Intimation Extension Of Time For Holding Annual General Meeting Of The Company For The Financial Year Ended On March 31 2025. | View |